Timing of Cardio-Kidney Protection With SGLT2 Inhibitors: Insights From 4 Large-Scale Placebo-Controlled Outcome Trials
Brendon L. Neuen, Brian Claggett, Vlado Perkovic, Meg Jardine, Hiddo J.L. Heerspink, Kenneth W. Mahaffey, John J.V. McMurray, Scott D. Solomon, Muthiah Vaduganathan
Topics & Concepts
MedicinePlaceboClinical trialKidneyPharmacologyIntensive care medicineInternal medicinePathologyAlternative medicineDiabetes Treatment and ManagementPotassium and Related DisordersHeart Failure Treatment and Management